Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Opat

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Internal Medicine Journal|July 8, 2017
Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucilConstantine Tam, Bryone Kuss, Stephen Opat, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Antiplatelet therapy: present status and future prospectsJustin R Hamilton, Zane Kaplan, Shaun P Jackson, et al.
Journal of Medical Microbiology|October 16, 2010
Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemiaNatasha E Holmes, Stephen Opat, Anthony Kelman, et al.
Internal Medicine Journal|November 11, 2023
Australian data on the utilisation and duration on treatment of ibrutinib with a proton pump inhibitor in patients with relapsed or refractory chronic lymphocytic leukaemiaRoss Salvaris, Stephen Mulligan, Andrea Puig, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
Hematologic Malignancy: Who Cares in the End? A Retrospective Cohort Study of Markers of Quality End-of-Life CareBriony Shaw, Catriona Parker, Stephen Opat, et al.
Blood Cancer Journal|September 11, 2023
Zanubrutinib: past, present, and futureConstantine S Tam, Javier L Muñoz, John F Seymour, et al.
Blood Cancer Journal|October 2, 2023
Correction: Zanubrutinib: past, present, and futureConstantine S Tam, Javier L Muñoz, John F Seymour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2023
Reply to Y. Song et alMeletios A Dimopoulos, Stephen Opat, Steven P Treon, et al.
Annals of Hematology|November 27, 2010
Failure of eculizumab to correct paroxysmal cold hemoglobinuriaGareth Peter Gregory, Stephen Opat, Hang Quach, et al.
Access Microbiology|September 25, 2020
Persistently positive culture of antimicrobial-susceptible <i>Legionella pneumophila</i> despite appropriate therapyNastaran Rafiei, Briony Shaw, Claire Dendle, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Internal Medicine Journal|July 8, 2017
Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucilConstantine Tam, Bryone Kuss, Stephen Opat, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Antiplatelet therapy: present status and future prospectsJustin R Hamilton, Zane Kaplan, Shaun P Jackson, et al.
Journal of Medical Microbiology|October 16, 2010
Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemiaNatasha E Holmes, Stephen Opat, Anthony Kelman, et al.
Internal Medicine Journal|November 11, 2023
Australian data on the utilisation and duration on treatment of ibrutinib with a proton pump inhibitor in patients with relapsed or refractory chronic lymphocytic leukaemiaRoss Salvaris, Stephen Mulligan, Andrea Puig, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
Hematologic Malignancy: Who Cares in the End? A Retrospective Cohort Study of Markers of Quality End-of-Life CareBriony Shaw, Catriona Parker, Stephen Opat, et al.
Blood Cancer Journal|September 11, 2023
Zanubrutinib: past, present, and futureConstantine S Tam, Javier L Muñoz, John F Seymour, et al.
Blood Cancer Journal|October 2, 2023
Correction: Zanubrutinib: past, present, and futureConstantine S Tam, Javier L Muñoz, John F Seymour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2023
Reply to Y. Song et alMeletios A Dimopoulos, Stephen Opat, Steven P Treon, et al.
Annals of Hematology|November 27, 2010
Failure of eculizumab to correct paroxysmal cold hemoglobinuriaGareth Peter Gregory, Stephen Opat, Hang Quach, et al.
Access Microbiology|September 25, 2020
Persistently positive culture of antimicrobial-susceptible <i>Legionella pneumophila</i> despite appropriate therapyNastaran Rafiei, Briony Shaw, Claire Dendle, et al.
Pageof 13